AAV
Testing
Viral Vectors
Minaris delivers end-to-end viral vector solutions designed to accelerate the development of advanced therapies. At the center of our AAV offering is TESSA® (Tetracycline-Enabled Self-Silencing Adenovirus) – a plamid-free production technology.
